All-Trans-Retinoic Acid Induction Overcomes Immune Evasion through Downregulating Immune Checkpoint Molecules and Inducing a Cytokine Storm Triggered By Overexpression of S100A8/A9 Signaling
Suning Chen(Soochow University), Depei Wu(Zhejiang Chinese Medical University), Xiaofei Yang(Shanxi Medical University), Qinrong Wang(Yale Cancer Center), Shengli Xue(Soochow University), Xiaowen Tang(Soochow University), Hongjie Shen(Soochow University), Zhao Zeng(Soochow University), Sudan He(Chinese Academy of Medical Sciences & Peking Union Medical College), Yusha Guo(Soochow University), Yi Xu(Beijing University of Chinese Medicine), Xiebing Bao(Soochow University), Jing-Ren Zhang(Tsinghua University), Haohao Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jinlan Pan(Soochow University), Qian Wang(Soochow University), Lijuan Gao(Zhongda Hospital Southeast University), Dandan Liu(Heilongjiang Provincial Academy of Agricultural Sciences), Tingting Zhang(Zhengzhou University), Zheng Wang(Office of Infectious Diseases), Zhibo Zhang(Nanjing Drum Tower Hospital), Yang Xu(Jilin University), Ying Wang(Hebei Medical University), Miao Miao(Soochow University), Mingqing Zhu(Soochow University), Qian Wu(University of Connecticut), Huiying Qiu(Soochow University), Jiannong Cen(Soochow University), Lijun Wen(Fox Chase Cancer Center), Yayun Du(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianhong Fu(Soochow University)
Cited by 0
Related Papers
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|238
Evidence of Marginal-Zone B Cell- Positive Selection in Spleen
|Immunity|2005|166
Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of <i>EP300</i> and <i>CREBBP</i>
|Genome Research|2016|140
Positive Selection of Anti–Thy-1 Autoreactive B-1 Cells and Natural Serum Autoantibody Production Independent from Bone Marrow B Cell Development
|The Journal of Experimental Medicine|2003|129
Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis
|Frontiers in Oncology|2021|125